Literature DB >> 21344443

Better performance with bone-anchored hearing aid than acoustic devices in patients with severe air-bone gap.

Maarten J F de Wolf1, Sander Hendrix, Cor W R J Cremers, Ad F M Snik.   

Abstract

OBJECTIVES/HYPOTHESIS: A study performed in the 1990s with analogue linear hearing aids showed that in patients with mixed hearing loss and an air-bone gap that exceeded 25 to 30 dB, speech perception was better with a bone-anchored hearing aid (Baha) than with a conventional behind-the-ear (BTE) device. The objective of the present study was to investigate whether this conclusion applies to today's digital BTEs with feedback cancellation and whether the crossover point still occurs at an air-bone gap of 25 to 30 dB. STUDY
DESIGN: Case control.
METHODS: Experienced unilateral Baha users with the latest digital Baha processors were fitted with a powerful BTE with feedback cancellation. After an acclimatization period of 4 weeks, aided thresholds and speech recognition scores were determined and compared to those recorded previously with the Baha. To obtain patients' opinions, a disability-specific questionnaire was used. Participants comprised 16 subjects with bilateral mixed hearing loss participated
RESULTS: Audiometric and speech recognition data showed similar trends to those described previously, but the crossover point had shifted to an air-bone gap of 30 to 35 dB. In the questionnaire, the BTE was rated higher than the Baha, except by the patients with an air-bone gap that exceeded an average of 45 dB.
CONCLUSIONS: In patients with mixed hearing loss whose air-bone gap exceeded 35 dB, speech recognition is likely to be better with a Baha than with a BTE. Therefore, the Baha should receive greater consideration when mixed hearing loss is combined with a significant air-bone gap, even when there are no contraindications for BTEs.
Copyright © 2010 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21344443     DOI: 10.1002/lary.21167

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Percutaneous bone-anchored hearing implant surgery: linear incision technique with tissue preservation versus linear incision technique with tissue reduction.

Authors:  E H H van der Stee; R M Strijbos; S J H Bom; M K S Hol
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-30       Impact factor: 2.503

2.  Rapid imaging of tympanic membrane vibrations in humans.

Authors:  Matan Hamra; Shadi Shinnawi; Mauricio Cohen Vaizer; Dvir Yelin
Journal:  Biomed Opt Express       Date:  2020-10-19       Impact factor: 3.732

3.  Indications and outcome of subtotal petrosectomy for active middle ear implants.

Authors:  Nicolas Verhaert; Hamidreza Mojallal; Burkard Schwab
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-25       Impact factor: 2.503

4.  Bone-anchored hearing aids in conductive and mixed hearing losses: why do patients reject them?

Authors:  Richard T K Siau; Baljeet Dhillon; Derrick Siau; Kevin M J Green
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-19       Impact factor: 2.503

5.  Hearing performance benefits of a programmable power baha® sound processor with a directional microphone for patients with a mixed hearing loss.

Authors:  Mark C Flynn; Annelen Hedin; Glenn Halvarsson; Tobias Good; Andre Sadeghi
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-04-30       Impact factor: 3.372

Review 6.  Implantable hearing devices.

Authors:  Matthias Tisch
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

7.  Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities.

Authors:  Simon Geerse; Tim J M Bost; Samira Allagul; Maarten J F de Wolf; Fenna A Ebbens; Erik van Spronsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-22       Impact factor: 2.503

8.  Hearing Rehabilitation of Patients with Chronic Otitis Media: A Discussion of Current State of Knowledge and Research Priorities.

Authors:  Douglas Backous; Byung Yoon Choi; Rafael Jaramillo; Kelvin Kong; Thomas Lenarz; Jaydip Ray; Alok Thakar; Myrthe K S Hol
Journal:  J Int Adv Otol       Date:  2022-07       Impact factor: 1.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.